Ruangang Pan

1.1k total citations
26 papers, 611 citations indexed

About

Ruangang Pan is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Ruangang Pan has authored 26 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Ruangang Pan's work include SARS-CoV-2 and COVID-19 Research (10 papers), interferon and immune responses (5 papers) and Influenza Virus Research Studies (4 papers). Ruangang Pan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), interferon and immune responses (5 papers) and Influenza Virus Research Studies (4 papers). Ruangang Pan collaborates with scholars based in China, United States and Switzerland. Ruangang Pan's co-authors include Deyin Guo, Yu Chen, Xiufen Zou, Yingming Sun, Yuanyuan Li, Suoqin Jin, Zishu Pan, Stanley Perlman, Tero Ahola and Shan Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Immunology.

In The Last Decade

Ruangang Pan

24 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruangang Pan China 14 222 201 195 113 67 26 611
Kailang Wu China 14 304 1.4× 439 2.2× 145 0.7× 128 1.1× 55 0.8× 20 897
Wilson W. Ng Hong Kong 12 354 1.6× 173 0.9× 118 0.6× 140 1.2× 32 0.5× 17 735
Diede Oudshoorn Netherlands 6 441 2.0× 163 0.8× 150 0.8× 83 0.7× 38 0.6× 6 644
Chun‐Kit Yuen Hong Kong 11 408 1.8× 134 0.7× 197 1.0× 67 0.6× 32 0.5× 13 603
Aimée St. Clair Tallarico United States 9 577 2.6× 273 1.4× 242 1.2× 174 1.5× 51 0.8× 10 995
Palaniappan Ramanathan United States 18 388 1.7× 223 1.1× 195 1.0× 187 1.7× 52 0.8× 44 927
Florian Wrensch Germany 14 496 2.2× 158 0.8× 240 1.2× 273 2.4× 48 0.7× 19 868
Camille R. Simoneau United States 8 272 1.2× 183 0.9× 259 1.3× 77 0.7× 71 1.1× 11 679
Kartika Padhan United States 12 291 1.3× 169 0.8× 184 0.9× 58 0.5× 27 0.4× 16 546
Nicole A. P. Lieberman United States 16 316 1.4× 264 1.3× 246 1.3× 169 1.5× 142 2.1× 33 903

Countries citing papers authored by Ruangang Pan

Since Specialization
Citations

This map shows the geographic impact of Ruangang Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruangang Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruangang Pan more than expected).

Fields of papers citing papers by Ruangang Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruangang Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruangang Pan. The network helps show where Ruangang Pan may publish in the future.

Co-authorship network of co-authors of Ruangang Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Ruangang Pan. A scholar is included among the top collaborators of Ruangang Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruangang Pan. Ruangang Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Ruangang, David K. Meyerholz, & Stanley Perlman. (2025). Cells that survive acute SARS-CoV-2 infection contribute to inflammation and lung regeneration in mice. mBio. 16(3). e0369324–e0369324.
2.
Ye, Gang, Fan Bu, Ruangang Pan, et al.. (2024). Structure-guided in vitro evolution of nanobodies targeting new viral variants. PLoS Pathogens. 20(9). e1012600–e1012600. 5 indexed citations
3.
Ye, Gang, Fan Bu, Ruangang Pan, et al.. (2024). Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. PLoS Pathogens. 20(9). e1012493–e1012493. 3 indexed citations
4.
Ye, Gang, Ruangang Pan, Fan Bu, et al.. (2023). Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. Journal of Virology. 97(11). e0144823–e0144823. 14 indexed citations
5.
Pan, Ruangang, David K. Meyerholz, & Stanley Perlman. (2023). Cells that survive acute murine SARS-CoV-2 infection are detected nearly exclusively in the respiratory tract. Journal of Clinical Investigation. 133(22). 4 indexed citations
6.
Pan, Ruangang, Scott M. Anthony, Yu Zhou, et al.. (2020). Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proceedings of the National Academy of Sciences. 117(27). 15902–15910. 34 indexed citations
7.
Zhan, Jianbo, Jing Cheng, Bing Hu, et al.. (2017). Pathogens and epidemiologic feature of severe fever with thrombocytopenia syndrome in Hubei province, China. Virus Research. 232. 63–68. 10 indexed citations
8.
Li, Shun, Mingzhu Zhu, Ruangang Pan, et al.. (2015). The tumor suppressor PTEN has a critical role in antiviral innate immunity. Nature Immunology. 17(3). 241–249. 141 indexed citations
9.
Jin, Suoqin, Yuanyuan Li, Ruangang Pan, & Xiufen Zou. (2014). Characterizing and controlling the inflammatory network during influenza A virus infection. Scientific Reports. 4(1). 3799–3799. 52 indexed citations
10.
Pan, Ruangang, et al.. (2012). Modeling and Dynamical Analysis of Virus-Triggered Innate Immune Signaling Pathways. PLoS ONE. 7(10). e48114–e48114. 23 indexed citations
11.
Luo, Mengcheng, Xiao Qu, Ruangang Pan, et al.. (2011). The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice. Vaccine. 29(14). 2561–2567. 15 indexed citations
12.
Pan, Ruangang, et al.. (2009). Glycosylation of classical swine fever virus Erns is essential for binding double-stranded RNA and preventing interferon-beta induction. Virus Research. 146(1-2). 135–139. 12 indexed citations
14.
Pan, Ruangang, et al.. (1988). [Astemizole in the treatment of acute rhinopharyngitis (common cold). A double-blind study in pediatrics].. PubMed. 108(11). 961–6. 3 indexed citations
15.
Pan, Ruangang. (1971). La vacunación contra el sarampión. 32(4). 311–316. 2 indexed citations
16.
Bütler, R., et al.. (1968). Susceptibility to infection and IgA deficiency in the infant. The Journal of Pediatrics. 72(1). 29–33. 13 indexed citations
17.
Pan, Ruangang, et al.. (1959). Das Verhalten der intramuskulär, intravenös und per os verabreichten Gammaglobuline. Annals of Hematology. 5(2). 104–114. 15 indexed citations
18.
Pan, Ruangang. (1958). The vaccination of the newborn infant against pertussis. The Journal of Pediatrics. 53(2). 180–186. 12 indexed citations
19.
Scheidegger, J J & Ruangang Pan. (1957). An immuno-electrophoretic study of serum proteins in newborn and young infants.. 6. 135–144.
20.
Pan, Ruangang, et al.. (1955). The psychologic development of a group of children brought up in a hospital type residential nursery. The Journal of Pediatrics. 47(1). 124–129. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026